HOXA1 and neoplasm: Consistently, in our study, in order to find a therapeutic target for the treatment of OSCC, we proposed a hypothesis that miR-145 could hinder OSCC cell invasion and migration and suppress tumor growth through regulation of HOXA1 and the ERK/MAPK signaling pathway.